National Health Investors (NHI) announced that proxy advisory firm Egan-Jones has recommended that stockholders vote on the white proxy card for only NHI’s director nominees – Candice Todd, Robert Chapin, Jr., James Jobe and Robert Adams – in connection with its May 21 annual meeting of stockholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- Is NHI a Buy, Before Earnings?
- National Health Investors price target lowered to $83 from $91 at BofA
- Land & Buildings urges National Health stockholders to vote for its nominees
- National Health Investors appoints Robert Chapin Jr. to board of directors
- National Health Investors price target raised to $76 from $70 at Truist